Author

E. Munoz-Couselo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Garcia-Garijo· 1 shared A. Gros· 1 shared A. Schlosser· 1 shared A. Vidal· 1 shared A. Yuste-Estevanez· 1 shared B. Ferrer· 1 shared E. Garralda· 1 shared E. Gonzlez-Sanchez· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Garcia-Garijo

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Loss of Lkb1 cooperates with BrafV600E and UV radiation increasing melanoma multiplicity and neural-like dedifferentiation

K. A. McGrail, E. Gonzlez-Sanchez, P. Granado-Martinez, R. Orsenigo, Y. Ding, B. Ferrer, J. Hernandez-Losa, I. Ortega, J. Martin-Caballero, E. Munoz-Couselo, V. Garcia-Patos, J. A. Recio

bioRxiv · Mar 29, 2024 · PreprintCancer Biology

Immunogenicity of non-canonical HLA-tumor ligands identified through proteogenomics

M. Lozano-Rabella, A. Garcia-Garijo, J. Palomero, A. Yuste-Estevanez, F. Erhard, J. Martin-Liberal, M. Ochoa de Olza, I. Matos, J. J. Gartner, M. Ghosh, F. Canals, A. Vidal, J. M. Piulats, X. Matias-Guiu, I. Brana, , A. Gros

The paper investigates the immunogenicity of non-canonical HLA-I ligands from tumor cells and finds they are not recognized by autologous T-cells but can be targeted by donor T-cells, suggesting potential as immunotherapy targets.

Clinical Cancer Research · Feb 7, 2023Peer-reviewedCancer Biology